Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of AmericaLeonard A. Mermel, David K. Warren, Michael Allon et al.|Clinical Infectious Diseases|2009Cited by 3.6k
Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral TherapyPatricia M. Flynn, Jane C. Lindsey, Bret J. Rudy et al.|The Journal of Infectious Diseases|2004Cited by 101
Long-Term Observation of Adolescents Initiating HAART Therapy: Three-Year Follow-UpPatricia M. Flynn, Bret J. Rudy, Jane C. Lindsey et al.|AIDS Research and Human Retroviruses|2007Cited by 65
Immune Reconstitution and Predictors of Virologic Failure in Adolescents Infected through Risk Behaviors and Initiating HAART: Week 60 Results from the PACTG 381 CohortBret J. Rudy, Steven D. Douglas, Jane C. Lindsey et al.|AIDS Research and Human Retroviruses|2006Cited by 35
Efavirenz liquid formulation in human immunodeficiency virus-infected childrenStuart E. Starr, Mark W. Kline, Stephen A. Spector et al.|The Pediatric Infectious Disease Journal|2002Cited by 34